Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NFATC3 |
| Upstream (Parents) |
|---|
| (<<) ACTB → NFATC3 |
| (<<) ARHGEF2 → NFATC3 |
| (<<) ATP2A2 → NFATC3 |
| (<<) ENO1 → NFATC3 |
| (<<) FOXO3 → NFATC3 |
| (<<) GAPDH → NFATC3 |
| (<<) MCL1 → NFATC3 |
| (<<) NFKB2 → NFATC3 |
| (<<) PPIB → NFATC3 |
| (<<) RAC2 → NFATC3 |
| (<<) RAVER1 → NFATC3 |
| (<<) RHOA → NFATC3 |
| (<<) RPS16 → NFATC3 |
| (<<) THOC4 → NFATC3 |
| (<<) TPP1 → NFATC3 |
| Downstream (Children) |
|---|
| NFATC3 → CIRH1A (>>) |
| NFATC3 → COL13A1 (>>) |
| NFATC3 → EVX1 (>>) |
| NFATC3 → LRP5 (>>) |
| NFATC3 → MSN (>>) |
| NFATC3 → NDST1 (>>) |
| NFATC3 → NFKBIZ (>>) |
| NFATC3 → PHLDA2 (>>) |
| NFATC3 → PLEK2 (>>) |
| NFATC3 → RAB15 (>>) |
| NFATC3 → RASD1 (>>) |
| NFATC3 → RHOT1 (>>) |
| NFATC3 → RPL26L1 (>>) |
| NFATC3 → TMEFF2 (>>) |
